Shimadzu Corporation: Analysis of correlation between matcha and amyloid β content in the brain Thursday June 21st, 2018By Tokio X'press Alzheimer, medical service SHIMADZU
Hitachi Zosen: Development and sale of “Sterilization / Decontamination Pass Box” for Sterilization for Regenerative Medicine Friday June 22nd, 2018By Tokio X'press IPS, 5 Science hitachizosen
Opivibo, the first cancer immunotherapy drug in China, approved by the Chinese National Drug Administration and Supervision Agency for indications of treatment non-small cell lung cancer with history Monday June 18th, 2018By Tokio X'press Cancer ONO
💊Hokkaido University: Elucidation of proteins that hold the key to invasion of influenza virus Monday May 28th, 2018By Tokio X'press disease, 5 Science, University
🔬RIKEN: Elucidation of the relation between genome integration of hepatitis B virus and canceration Wednesday May 23rd, 2018By Tokio X'press Cancer, disease Riken